IL140388A0 - Aryl phosphate derivatives of d4t having anti-hiv activity - Google Patents

Aryl phosphate derivatives of d4t having anti-hiv activity

Info

Publication number
IL140388A0
IL140388A0 IL14038899A IL14038899A IL140388A0 IL 140388 A0 IL140388 A0 IL 140388A0 IL 14038899 A IL14038899 A IL 14038899A IL 14038899 A IL14038899 A IL 14038899A IL 140388 A0 IL140388 A0 IL 140388A0
Authority
IL
Israel
Prior art keywords
aryl phosphate
phosphate derivatives
derivatives
group
hiv activity
Prior art date
Application number
IL14038899A
Other languages
English (en)
Original Assignee
Parker Hughes Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parker Hughes Inst filed Critical Parker Hughes Inst
Publication of IL140388A0 publication Critical patent/IL140388A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL14038899A 1998-06-29 1999-06-29 Aryl phosphate derivatives of d4t having anti-hiv activity IL140388A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/107,716 US6030957A (en) 1998-06-29 1998-06-29 Aryl phosphate derivatives of d4T having anti-HIV activity
PCT/US1999/014774 WO2000000501A1 (fr) 1998-06-29 1999-06-29 Derives de phosphate arylique de d4t possedant une activite anti-vih

Publications (1)

Publication Number Publication Date
IL140388A0 true IL140388A0 (en) 2002-02-10

Family

ID=22318071

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14038899A IL140388A0 (en) 1998-06-29 1999-06-29 Aryl phosphate derivatives of d4t having anti-hiv activity

Country Status (14)

Country Link
US (7) US6030957A (fr)
EP (1) EP1090018B1 (fr)
JP (1) JP2002519355A (fr)
KR (1) KR20010071673A (fr)
CN (1) CN1314909A (fr)
AT (1) ATE277940T1 (fr)
AU (1) AU4846999A (fr)
BR (1) BR9911685A (fr)
CA (1) CA2336285A1 (fr)
DE (1) DE69920696T2 (fr)
HU (1) HUP0102527A3 (fr)
IL (1) IL140388A0 (fr)
NO (1) NO20006685L (fr)
WO (1) WO2000000501A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070015733A1 (en) * 1998-06-29 2007-01-18 Parker Hughes Institute Aryl Phosphate Derivatives of d4T having Activity Against Resistant HIV Strains
US7144874B2 (en) * 2002-10-25 2006-12-05 Parker Hughes Institute Aryl phosphate derivatives of d4T having activity against resistant HIV strains
US6030957A (en) * 1998-06-29 2000-02-29 Wayne Hughes Institute Aryl phosphate derivatives of d4T having anti-HIV activity
WO2000056750A1 (fr) * 1999-03-19 2000-09-28 Parker Hughes Institute Synthese monotope de derives de nucleosides 5'-hydroxy-phosphorylés et composés se formant de cette façon
US6825177B2 (en) * 2000-10-30 2004-11-30 Parker Hughes Institute Aryl phosphate derivatives of d4T with potent anti-viral activity
ES2240234T3 (es) * 2000-11-13 2005-10-16 Parker Hughes Institute Derivados de fosfato de arilo de d4t.
US7405202B2 (en) * 2002-05-28 2008-07-29 Regents Of The University Of Minnesota CRISP polypeptides as contraceptives and inhibitors of sperm capacitation
US20030236218A1 (en) * 2002-06-12 2003-12-25 Uckun Fatih M. Aryl phosphate derivatives of d4T with selective activity against adenovirus and HIV
US20040076931A1 (en) * 2002-10-18 2004-04-22 Cashflow Technologies, Inc. Educational interactive games
US20040077607A1 (en) * 2002-10-21 2004-04-22 Uckun Fatih M. Aryl phosphate derivatives of d4T with potent anti-viral activity against hemorrhagic fever viruses
GB0401088D0 (en) 2004-01-19 2004-02-18 Univ Cardiff Phosphoramidate derivatives
EP1773355B1 (fr) * 2004-06-24 2014-06-25 Merck Sharp & Dohme Corp. Phosphoramidates d'aryle nucleosidiques pour le traitement d'infection virale arn dependante de l'arn
WO2006026656A1 (fr) * 2004-08-31 2006-03-09 Parker Hughes Institute Compose analogue de nucleoside cytotoxique 003 pour le traitement du cancer
EP1827460A4 (fr) 2004-12-09 2012-03-14 Univ Minnesota Nucleosides presentant une activite antivirale et anticancereuse
KR20080003789A (ko) * 2005-03-09 2008-01-08 더 리전츠 오브 더 유니버시티 오브 캘리포니아 나노복합체막 및 이의 제조 및 사용 방법
US7892618B2 (en) 2005-03-21 2011-02-22 Sony Corporation Deterring theft of optical media
GB0623493D0 (en) * 2006-11-24 2007-01-03 Univ Cardiff Chemical compounds
EP2408306A4 (fr) * 2009-03-20 2012-11-07 Alios Biopharma Inc Nucleoside substitue et analogues nucleotidiques
SG188497A1 (en) 2010-09-22 2013-05-31 Alios Biopharma Inc Substituted nucleotide analogs
CN103403014B (zh) * 2011-01-03 2016-07-06 河南美泰宝生物制药有限公司 O-(经取代的苯甲基)氨基磷酸酯化合物及其治疗用途
CA2860234A1 (fr) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Analogues de nucleotide phosphorothioate substitue
US8916538B2 (en) 2012-03-21 2014-12-23 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
WO2013142157A1 (fr) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Combinaisons pharmaceutiques comprenant un analogue thionucléotidique
CA2909270A1 (fr) 2013-04-12 2014-10-16 Achillion Pharmaceuticals, Inc. Derive de nucleoside d'activite elevee pour le traitement du vhc

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707362A (en) 1985-02-15 1987-11-17 Biotek, Inc. Sustained release composition
US4841039A (en) 1986-05-01 1989-06-20 Emory University 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents
US4983393A (en) 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
JPH06189998A (ja) 1992-11-06 1994-07-12 C & Co:Yugen コンド―ム
EP0626970A1 (fr) 1992-12-18 1994-12-07 The University Of Alberta Nucleosides de dihydropyrimidine a proprietes antivirales
ZA947572B (en) 1993-09-29 1995-09-28 Hampton Roads Medical College Contraceptive compositions
US5672698A (en) * 1993-11-15 1997-09-30 Bristol-Myers Squibb Co. Preparation of 2',3'-didehydro-3'-deoxythymidine from 5-methyluridine
US5659023A (en) * 1995-02-01 1997-08-19 Gilead Sciences, Inc. Nucleotide analogues
GB9505025D0 (en) * 1995-03-13 1995-05-03 Medical Res Council Chemical compounds
CN1177594C (zh) 1996-05-09 2004-12-01 传染病研究股份有限公司 预防治疗粘膜皮肤各种感染 (特别是包括人类免疫缺陷病毒的性传播性疾病 )、炎症、赘生物或其他类型疾病的方法和制剂
US6030957A (en) * 1998-06-29 2000-02-29 Wayne Hughes Institute Aryl phosphate derivatives of d4T having anti-HIV activity

Also Published As

Publication number Publication date
DE69920696T2 (de) 2006-03-02
US6670336B1 (en) 2003-12-30
AU4846999A (en) 2000-01-17
US6537975B1 (en) 2003-03-25
US6030957A (en) 2000-02-29
HUP0102527A2 (hu) 2001-12-28
JP2002519355A (ja) 2002-07-02
BR9911685A (pt) 2001-12-18
EP1090018B1 (fr) 2004-09-29
HUP0102527A3 (en) 2002-04-29
DE69920696D1 (de) 2004-11-04
CA2336285A1 (fr) 2000-01-06
WO2000000501A1 (fr) 2000-01-06
US6350736B1 (en) 2002-02-26
NO20006685L (no) 2001-02-28
US6503890B1 (en) 2003-01-07
US6528495B1 (en) 2003-03-04
KR20010071673A (ko) 2001-07-31
NO20006685D0 (no) 2000-12-28
EP1090018A1 (fr) 2001-04-11
CN1314909A (zh) 2001-09-26
US20040171577A1 (en) 2004-09-02
US7071176B2 (en) 2006-07-04
ATE277940T1 (de) 2004-10-15

Similar Documents

Publication Publication Date Title
IL140388A0 (en) Aryl phosphate derivatives of d4t having anti-hiv activity
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
EP0810209A3 (fr) Sulfamides d'hydroxyéthylamino utiles comme inhibiteurs de protéases rétrovirales
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
PL337329A1 (en) Oxazolydinone based antibacterial agents comprising a thiocarbonyl functional group
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
BG103335A (en) Application of fumaric acid derivatives
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
BG103485A (en) Ketobanzamides as calpain inhibitors
AU1694295A (en) Benzoxazinones as inhibitors of hiv reverse transcriptase
ES2173341T3 (es) Compuestos inhibidores de proteasa retroviral.
TR199903148T2 (xx) Antimetastatik ve antit�m�r etkinli�i olan barbit�rik asit t�revleri.
MX9706913A (es) Compuestos de bis-aminacido-hidroxietilamina-sulfonamida inhibidoresde proteasan retroviral, composiciones que los contienen y ek uso de los mismos.
CA2278694A1 (fr) Inhibiteurs de sulfamide-metalloprotease
AU6797298A (en) Halo-alkoxycarbonyl prodrugs
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
WO1999058526A8 (fr) Nouveaux derives d'acide 2,5-pyridinecarboxylique
ZA955793B (en) Benzothiadiazine compound process for its preparation and the pharmaceutical compositions which contain it
HUP0202729A2 (hu) Ösztramusztin-foszfátot és aminosavakat tartalmazó, parenteralis felhasználásra szolgáló készítmények
WO1992009574A3 (fr) Derives polyaminopyrrolecarboxamido, leurs procedes de preparation et compositions pharmaceutiques les contenant
NZ213432A (en) Antihypertensive dipeptide derivatives and pharmaceutical compositions
EP0333000A3 (en) Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them
DE60020891D1 (de) Arylphosphatderivate von d4t
AU4511299A (en) Imidazotriazolopyrimidines used as a drug having an adenosine antagonist activity
EP0355409A3 (fr) L'utilisation d'un inhibiteur de prolylendopeptidase pour le traitement du SIDA